The Chart of the Day is Seattle Genetics (SGEN) and was found by sorting the Barchart New High list for
frequency then using the Flipchart function to review the charts. In
the last month the stock rose in 17 session for a gain of 29.63% and has
a Trend Spotter buy signal. It has great fundamentals for next year.
The
Company develops monoclonal antibody-based drugs to treat cancer and
related diseases. Using its monoclonal antibody-based technologies and
its expertise in cancer, they have assembled a portfolio of drug
candidates targeted to many types of human cancers.
Please share this article
No comments:
Post a Comment